In contrast, a very lean, muscular person might require the higher end (or beyond) when trying to cut body fat
(1) Because people with type 2 diabetes who start using an SGLT2i or GLP-1 RA will probably delay initiation of another glucose-lowering medication, costs will be saved
Blood Sugar Regulation Studies in mice indicate that MT-IIs stimulation of the MC-3 and MC-4 receptors affects blood glucose levels, augmenting insulin sensitivity
Each receptor contributes a different effect: GLP-1: reduces appetite and slows gastric emptying GIP: enhances insulin response and metabolic signaling Glucagon: increases energy expenditure and promotes fat utilization What makes retatrutide particularly notable is the level of clinical data supporting it
In preclinical studies, cotadutide demonstrated a more pronounced loss of body weight, reduction in food intake, and superior improvement in glycemic parameters in rodents compared to a GLP-1 RA